Earnings Presentation on the Audited Financial Results of the Company for the Fourth Quarter (Q4) and Financial Year ended 31 March 2026
MPSLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
MPS Ltd reported record FY26 EPS of ₹102.11, up 16.3% YoY, with FY26 EBITDA of ₹236 Cr (margin 30.7%) and ROCE of 38.2%. Q4 FY26 revenue grew 12.66% YoY to ₹20,516 Lakhs, while EBITDA surged 20.53% YoY to ₹6,751 Lakhs, showing strong operating leverage. Management guided FY27 EBITDA of ₹300 Cr+, implying a ~21% 3-year EBITDA CAGR from FY24 to FY27. The Research segment remains the profit engine at 39.9% FY26 EBITDA margin, while Education is emerging as a second pillar with 36.26% revenue growth (including Unbound Medicine acquisition). The company operates across Research Solutions, Education Solutions, and Corporate Learning, with AI deployed in production across all three segments.
Strong earnings beat with margin expansion signals solid execution. Management's explicit FY27 ₹300 Cr+ EBITDA guidance provides clear multi-year targets for investors, while the ROCE of 38.2% reflects high capital efficiency.